Jamie L. Reynoso - 07 Sep 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO of Medicare Advantage
Signature: /s /Scott Leffler as attorney-in-fact for Jamie L. Reynoso
Issuer symbol: CLOV
Transactions as of: 07 Sep 2023
Net transactions value: -$69,387
Form type: 4
Filing time: 11 Sep 2023, 16:11:17 UTC
Previous filing: 16 Jun 2023
Next filing: 18 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Award	$0	+652,452	+47%	$0.000000	2,033,337	07 Sep 2023	Direct	F1
transaction	CLOV	Class A Common Stock	Tax liability	$69,387	-52,967	-2.6%	$1.31	1,980,370	07 Sep 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date.
F2	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.

Content

Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date.

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.